Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAMING study of low-dose amitriptyline and mirtazapine for insomnia disorder
NL-OMON50436Phase 3Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline, mirtazapine in Insomnia, sponsored by Vrije University Medical Center. Started Jan 2019; status: active, not recruiting.
02
Drugs
amitriptylinemirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON50436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50436.